AVAGE (Allergan, Inc.)
Welcome to the PulseAid listing for the AVAGE drug offered from Allergan, Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | tazarotene |
| SUBSTANCE NAME: | TAZAROTENE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
| ROUTE: | CUTANEOUS |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2003-01-07 |
| END MARKETING DATE: | 0000-00-00 |
AVAGE HUMAN PRESCRIPTION DRUG Details:
| Item Description | AVAGE from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/g) |
| START MARKETING DATE: | 2003-01-07 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0023-9236_a2e46dae-939c-4984-a003-59e0d00f18b4 |
| PRODUCT NDC: | 0023-9236 |
| APPLICATION NUMBER: | NDA021184 |
Other TAZAROTENE Pharmaceutical Manufacturers / Labelers:
